ArticleOncogene2017
Co-targeting of EGF receptor and neuropilin-1 overcomes cetuximab resistance in pancreatic ductal adenocarcinoma with integrin β1-driven Src-Akt bypass signaling.
Y-J Kim et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this papercites it